Fundraising FoxReaxbio
2 known investors
Find your way into Reaxbio
Sign up to see every warm intro you have to Reaxbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Reaxbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
Founders & leadership
JM
Jeff MontgomeryCo-Founder & Principal ScientistJeff Montgomery is a chemical biologist with expertise in peptides, proteins, and assay development. He founded Reaxbio, which develops chemoproteomics platforms for drug discovery.
Investors · 2
OMX Ventureslisted by OMX VenturesLincolnshire
How we know: OMX Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Reaxbio do?
- Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
- Who founded Reaxbio?
- Reaxbio was founded by Jeff Montgomery.
- Who are Reaxbio's investors?
- Reaxbio's investors include OMX Ventures, Portal Innovations.